CAMBRIDGE, Mass., Dec 28, 2007 (BUSINESS WIRE) -- Alkermes, Inc. (NASDAQ: ALKS) announced today that its corporate
presentation will be webcast live by Morgan Stanley on Friday, January
4, 2008 at 11:00 a.m. EST. The presentation will be webcast from
Morgan Stanley Headquarters in New York and may be accessed under the
investor relations tab at www.alkermes.com. The presentation will be
archived for 14 days.
Alkermes, Inc. is a biotechnology company that uses proprietary
technologies and know-how to create innovative medicines designed to
yield better therapeutic outcomes for patients with serious disease.
Alkermes manufactures RISPERDAL(R) CONSTA(R), marketed by
Janssen-Cilag (Janssen, L.P.), a wholly owned division of Johnson &
Johnson, and developed and manufactures VIVITROL(R), marketed in the
U.S. primarily by Cephalon, Inc. The company's pipeline includes
extended-release injectable, pulmonary and oral products for the
treatment of prevalent, chronic diseases, such as central nervous
system disorders, addiction and diabetes. Alkermes is headquartered in
Cambridge, Massachusetts, with research and manufacturing facilities
in Massachusetts and Ohio.
SOURCE: Alkermes, Inc.
Associate, Corporate Communications